Aclaris Therapeutics (ACRS) Other Accumulated Expenses (2014 - 2026)
Aclaris Therapeutics (ACRS) reported Other Accumulated Expenses of $2.79 million for Q2 2026, up 2.7% from $2.72 million a year earlier and up 0.7% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Other Accumulated Expenses (2014 - 2026) Analysis & Trends
At the end of FY2025, Aclaris Therapeutics posted Other Accumulated Expenses of $2.75 million, up 2.6% from FY2024.
- Other Accumulated Expenses has a five-year compound annual growth rate of 18.6% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $2.68 million in FY2024 (+2.1%), $2.63 million in FY2023, $217,000 in FY2022 (-87.5%) and $1.73 million in FY2021 (+47.7%).
- The Q2 2026 figure ranks as the highest quarterly Other Accumulated Expenses in data going back to Q4 2014.
- Year over year, Other Accumulated Expenses has now increased in each of the last five quarters, with growth averaging 48.9% over the last eight quarters.
- The high point for year-over-year Other Accumulated Expenses in five years was Q3 2024 (growth of 376.3%); the low point was Q4 2022 (a decline of 87.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.77 million (Q1 2026), $2.75 million (Q4 2025) and $2.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Aclaris Therapeutics | 613.83 Mn | 613.83 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.79 Mn |
| Mar 31, 2026 | 2.77 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | 2.72 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 2.71 Mn |
| Dec 31, 2023 | 2.63 Mn |
| Sep 30, 2023 | 560,000.00 |
| Jun 30, 2023 | 750,000.00 |
| Mar 31, 2023 | 570,000.00 |
| Dec 31, 2022 | 217,000.00 |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 1.92 Mn |
| Mar 31, 2022 | 1.68 Mn |
| Dec 31, 2021 | 1.73 Mn |
| Sep 30, 2021 | 669,000.00 |
API Access
Aclaris Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();